Predictive Clinical and Surgical Factors Associated with Recurrent Apoplexy in Pituitary Adenomas

Abstract

Introduction Pituitary apoplexy is an uncommon clinical condition that can require urgent surgical intervention, but the factors resulting in recurrent apoplexy remain unclear. The purpose of this study is to determine the risks of a recurrent apoplexy and better understand the goals of surgical treatment.

Methods A retrospective chart review was performed for all consecutive patients diagnosed and surgically treated for pituitary apoplexy from 2004 to 2021. Univariate analysis was performed to identify risk factors associated with recurrent apoplexy.

Results A total of 115 patients were diagnosed with pituitary apoplexy with 11 patients showing recurrent apoplexy. This occurred at a rate of 2.2 cases per 100 patient-years of follow-up. There were no major differences in demographic factors, such as hypertension or anticoagulation use. There were no differences in tumor locations, cavernous sinus invasion, or tumor volumes (6.84 ± 4.61 vs. 9.15 ± 8.45 cm, p = 0.5). Patients with recurrent apoplexy were less likely to present with headache (27.3%) or ophthalmoplegia (9.1%). Recurrent apoplexy was associated with prior radiation (0.0 vs. 27.3%, p = 0.0001) and prior subtotal resection (10.6 vs. 90.9%, p = 0.0001) compared with first time apoplexy. The mean time to recurrent apoplexy was 48.3 ± 76.9 months and no differences in overall follow-up were seen in this group.

Conclusion Recurrent pituitary apoplexy represents a rare event with limited understanding of pathophysiology. Prior STR and radiation treatment are associated with an increased risk. The relatively long time from the first apoplectic event to a recurrence suggests long-term patient follow-up is necessary.

Keywords

pituitary adenoma - apoplexy - endoscopic - recurrent hemorrhage - radiation

Publikationsverlauf

Eingereicht: 20. April 2021

Angenommen: 11. August 2021

Artikel online veröffentlicht:
10. September 2021

• References

• 1 Brougham M, Heusner AP, Adams RD. Acute degenerative changes in adenomas of the pituitary body—with special reference to pituitary apoplexy. J Neurosurg 1950; 7 (05) 421-439
• 2 Dubuisson AS, Beckers A, Stevenaert A. Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg 2007; 109 (01) 63-70
• 3 Sibal L, Ball SG, Connolly V. et al. Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary 2004; 7 (03) 157-163
• 4 Verrees M, Arafah BM, Selman WR. Pituitary tumor apoplexy: characteristics, treatment, and outcomes. Neurosurg Focus 2004; 16 (04) E6
• 5 Pal A, Capatina C, Tenreiro AP. et al. Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences. Clin Endocrinol (Oxf) 2011; 75 (04) 501-504
• 6 Sarwar KN, Huda MS, Van de Velde V. et al. The prevalence and natural history of pituitary hemorrhage in prolactinoma. J Clin Endocrinol Metab 2013; 98 (06) 2362-2367
• 7 Cinar N, Tekinel Y, Dagdelen S, Oruckaptan H, Soylemezoglu F, Erbas T. Cavernous sinus invasion might be a risk factor for apoplexy. Pituitary 2013; 16 (04) 483-489
• 8 Semple PL, Jane Jr JA, Laws Jr ER. Clinical relevance of precipitating factors in pituitary apoplexy. Neurosurgery 2007; 61 (05) 956-961 , discussion 961–962
• 9 Yamaji T, Ishibashi M, Kosaka K. et al. Pituitary apoplexy in acromegaly during bromocriptine therapy. Acta Endocrinol (Copenh) 1981; 98 (02) 171-177
• 10 Lee DH, Chung MY, Chung DJ. et al. Apoplexy of pituitary macroadenoma after combined test of anterior pituitary function. Endocr J 2000; 47 (03) 329-333
• 11 Weisberg LA. Pituitary apoplexy. Association of degenerative change in pituitary ademona with radiotherapy and detection by cerebral computed tomography. Am J Med 1977; 63 (01) 109-115
• 12 Biousse V, Newman NJ, Oyesiku NM. Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry 2001; 71 (04) 542-545
• 13 Kulah A, Erel C, Memis M, Sav A. Arrested puberty associated with apoplectic prolactinoma in a male adolescent. Childs Nerv Syst 1995; 11 (02) 124-127
• 14 Brisman MH, Katz G, Post KD. Symptoms of pituitary apoplexy rapidly reversed with bromocriptine. Case report. J Neurosurg 1996; 85 (06) 1153-1155
• 15 Bills DC, Meyer FB, Laws Jr ER. et al. A retrospective analysis of pituitary apoplexy. Neurosurgery 1993; 33 (04) 602-608 , discussion 608–609
• 16 Açikgöz B, Cağavi F, Hakki Tekkök I. Late recurrent bleeding after surgical treatment for pituitary apoplexy. J Clin Neurosci 2004; 11 (05) 555-559
• 17 Brown TV, Cheesman KC, Post KD. Recurrent pituitary apoplexy in an adenoma with switching phenotypes. AACE Clin Case Rep 2020; 6 (05) e221-e224
• 18 Hosmann A, Micko A, Frischer JM. et al. Multiple pituitary apoplexy-cavernous sinus invasion as major risk factor for recurrent hemorrhage. World Neurosurg 2019; 126: e723-e730
• 19 Teasdale S, Hashem F, Olson S, Ong B, Inder WJ. Recurrent pituitary apoplexy due to two successive neoplasms presenting with ocular paresis and epistaxis. Endocrinol Diabetes Metab Case Rep 2015; 2015: 140088
• 20 Goel A, Deogaonkar M, Desai K. Fatal postoperative ‘pituitary apoplexy’: its cause and management. Br J Neurosurg 1995; 9 (01) 37-40
• 21 Koutourousiou M, Gardner PA, Fernandez-Miranda JC, Paluzzi A, Wang EW, Snyderman CH. Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations. J Neurosurg 2013; 118 (03) 621-631
• 22 Pangal DJ, Chesney K, Memel Z. et al. Pituitary apoplexy case series: outcomes after endoscopic endonasal transsphenoidal surgery at a single tertiary center. World Neurosurg 2020; 137: e366-e372
• 23 Zaidi HA, Cote DJ, Burke WT. et al. Time course of symptomatic recovery after endoscopic transsphenoidal surgery for pituitary adenoma apoplexy in the modern era. World Neurosurg 2016; 96: 434-439
• 24 Farrell CJ, Nyquist GG, Farag AA, Rosen MR, Evans JJ. Principles of pituitary surgery. Otolaryngol Clin North Am 2016; 49 (01) 95-106
• 25 Oldfield EH, Merrill MJ. Apoplexy of pituitary adenomas: the perfect storm. J Neurosurg 2015; 122 (06) 1444-1449
• 26 Cardoso ER, Peterson EW. Pituitary apoplexy: a review. Neurosurgery 1984; 14 (03) 363-373
• 27 Chen L, White WL, Spetzler RF, Xu B. A prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome. J Neurooncol 2011; 102 (01) 129-138
• 28 Losa M, Mortini P, Barzaghi R. et al. Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J Neurosurg 2008; 108 (03) 525-532
• 29 Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) 1999; 51 (02) 181-188
• 30 McFadzean RM, Doyle D, Rampling R, Teasdale E, Teasdale G. Pituitary apoplexy and its effect on vision. Neurosurgery 1991; 29 (05) 669-675
• 31 Maccagnan P, Macedo CL, Kayath MJ, Nogueira RG, Abucham J. Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab 1995; 80 (07) 2190-2197
• 32 Seuk JW, Kim CH, Yang MS, Cheong JH, Kim JM. Visual outcome after transsphenoidal surgery in patients with pituitary apoplexy. J Korean Neurosurg Soc 2011; 49 (06) 339-344
• 33 Hage R, Eshraghi SR, Oyesiku NM. et al. Third, fourth, and sixth cranial nerve palsies in pituitary apoplexy. World Neurosurg 2016; 94: 447-452
• 34 Liu JK, Couldwell WT. Pituitary apoplexy in the magnetic resonance imaging era: clinical significance of sphenoid sinus mucosal thickening. J Neurosurg 2006; 104 (06) 892-898
• 35 Yang T, Bayad F, Schaberg MR. et al. Endoscopic endonasal transsphenoidal treatment of pituitary apoplexy: outcomes in a series of 20 patients. Cureus 2015; 7 (10) e357
• 36 Zhan R, Li X, Li X. Endoscopic endonasal transsphenoidal approach for apoplectic pituitary tumor: surgical outcomes and complications in 45 patients. J Neurol Surg B Skull Base 2016; 77 (01) 54-60
• 37 Bi WL, Dunn IF, Laws Jr ER. Pituitary apoplexy. Endocrine 2015; 48 (01) 69-75
• 38 Ostrov SG, Quencer RM, Hoffman JC, Davis PC, Hasso AN, David NJ. Hemorrhage within pituitary adenomas: how often associated with pituitary apoplexy syndrome?. AJR Am J Roentgenol 1989; 153 (01) 153-160
• 39 Mohr G, Hardy J. Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg Neurol 1982; 18 (03) 181-189
• 40 Kinoshita Y, Tominaga A, Usui S, Arita K, Sugiyama K, Kurisu K. Impact of subclinical haemorrhage on the pituitary gland in patients with pituitary adenomas. Clin Endocrinol (Oxf) 2014; 80 (05) 720-725
• 41 Onesti ST, Wisniewski T, Post KD. Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients. Neurosurgery 1990; 26 (06) 980-986
• 42 Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJ. Acute management of pituitary apoplexy—surgery or conservative management?. Clin Endocrinol (Oxf) 2004; 61 (06) 747-752
• 43 Tu M, Lu Q, Zhu P, Zheng W. Surgical versus non-surgical treatment for pituitary apoplexy: a systematic review and meta-analysis. J Neurol Sci 2016; 370: 258-262